Parkinson's disease
Conditions
Interventions
Traditional Chinese Medicine (TCM):electroacupuncture
Placebo:electroacupuncture simulation
Sponsors
Longhua Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ? According to the clinical diagnostic criteria of the Society for Movement Disorders, the diagnosis is idiopathic Parkinson's disease; ? Between the ages of 30 and 80; ? Diagnose stage 1-4 PD based on Hoehn and Yahr scales; ? Insomnia with a severity index (ISI) score of 15 or above; ? Have a stable anti PD treatment regimen for at least 4 weeks prior to entering the trial or new patients;
Exclusion criteria
Exclusion criteria: ? Suffering from atypical or secondary Parkinson's disease; ? Sleep apnea (defined as the apnea hypopnea index that accumulates more than 15 episodes of sleep apnea and hypopnea during screening to sleep monitoring (PSG) recording per hour of EEG sleep); ? Insomnia is related to restless leg syndrome, sleep disorders, or other sleep disorders; ? Schizophrenia, severe depression, or cognitive impairment (cognitive impairment is classified as cognitive impairment according to the definition of Mini Mental State Examination (MMMSE) for individuals who are illiterate, have only received primary education, or have received formal education higher than primary education, if the MMSE score is lower than 14, 20, or 24, respectively); ? He had received acupuncture and moxibustion treatment before participating; ? Have taken sedative and hypnotic drugs within the first three months of participation; ? Inability to use electroacupuncture or PSG due to pacemaker, epilepsy, skin diseases, limb defects, or other conditions; ? Pregnancy or lactation period; ? Suffering from serious cardiovascular and cerebrovascular diseases, hematopoietic system diseases, malignant tumors, or other serious life-threatening diseases; ? Within the past 3 months, use of metoclopramide, reserpine a- Methyldopa, methylphenidate or derivatives of amphetamine; ? Abuse of alcohol or drug dependence; ? Participate in other clinical trials within the first 3 months of participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PDSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Epworth Sleepiness Scale,ESS;Movement Disorder Society Unified Parkinson’s Rating Scale III;Parkinson's disease questionnaire,PDQ-39; | — |
Countries
China
Contacts
Public ContactCanxing Yuan
Longhua Hospital
Outcome results
None listed